Non-Structural Protein-W61 as a Novel Target in Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV): An In-Vitro and In-Silico Study on Protein-Protein Interactions with Nucleoprotein and Viral Replication.
SFTSV
in-vitro and in-silico analysis
protein-protein interaction
viral protein
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
20 09 2023
20 09 2023
Historique:
received:
04
08
2023
revised:
08
09
2023
accepted:
19
09
2023
medline:
23
10
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
The non-structural protein (NSs) and nucleoprotein (NP) of the severe fever with thrombocytopenia syndrome virus (SFTSV) encoded by the S segment are crucial for viral pathogenesis. They reside in viroplasm-like structures (VLS), but their interaction and their significance in viral propagation remain unclear. Here, we investigated the significance of the association between NSs and NP during viral infection through in-silico and in-vitro analyses. Through in-silico analysis, three possible binding sites were predicted, at positions C6S (Cystein at 6th position to Serine), W61Y (Tryptophan 61st to Tyrosine), and S207T (Serine 207th to Threonine), three mutants of NSs were developed by site-directed mutagenesis and tested for NP interaction by co-immunoprecipitation. NSsW61Y failed to interact with the nucleoprotein, which was substantiated by the conformational changes observed in the structural analyses. Additionally, molecular docking analysis corroborated that the NSW61Y mutant protein does not interact well compared to wild-type NSs. Over-expression of wild-type NSs in HeLa cells increased the SFTSV replication by five folds, but NSsW61Y exhibited 1.9-folds less viral replication than wild-type. We demonstrated that the W61Y alteration was implicated in the reduction of NSs-NP interaction and viral replication. Thus, the present study identified a critical NSs site, which could be targeted for development of therapeutic regimens against SFTSV.
Identifiants
pubmed: 37766369
pii: v15091963
doi: 10.3390/v15091963
pmc: PMC10535573
pii:
doi:
Substances chimiques
Nucleoproteins
0
Serine
452VLY9402
Viral Nonstructural Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
FASEB J. 2014 Jun;28(6):2504-16
pubmed: 24599967
Am J Trop Med Hyg. 2013 Sep;89(3):445-452
pubmed: 23878186
Parasitol Res. 2015 Dec;114(12):4703-7
pubmed: 26350381
J Virol. 2014 Mar;88(6):3605-9
pubmed: 24390329
Sci Rep. 2021 Nov 26;11(1):22977
pubmed: 34836987
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
J Immunol. 2019 Feb 1;202(3):841-856
pubmed: 30598516
N Engl J Med. 2012 Aug 30;367(9):834-41
pubmed: 22931317
J Mol Cell Biol. 2014 Aug;6(4):324-37
pubmed: 24706939
J Virol. 2017 Jul 27;91(16):
pubmed: 28592543
J Virol. 2015 Mar;89(6):3026-37
pubmed: 25552716
Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
Am J Trop Med Hyg. 2018 Jul;99(1):11-16
pubmed: 29692303
J Virol. 2010 Jul;84(13):6782-98
pubmed: 20335253
mSphere. 2017 Jun 28;2(3):
pubmed: 28680969
Viruses. 2013 Oct 04;5(10):2447-68
pubmed: 24100888
PLoS One. 2017 Feb 24;12(2):e0172744
pubmed: 28234991
Microb Pathog. 2020 Dec;149:104111
pubmed: 32135222
Crit Rev Microbiol. 2018 Sep;44(5):522-540
pubmed: 29516765
J Virol. 2015 Apr;89(8):4227-36
pubmed: 25631085
Microbes Infect. 2018 Jun - Jul;20(6):360-368
pubmed: 29886262
Emerg Infect Dis. 2014 Jun;20(6):1040-3
pubmed: 24856477
J Virol. 2014 Mar;88(6):3067-76
pubmed: 24335286
J Virol. 2020 Feb 28;94(6):
pubmed: 31852783
Exp Mol Med. 2021 May;53(5):713-722
pubmed: 33953322
Front Microbiol. 2021 Aug 16;12:709517
pubmed: 34484148
J Virol. 2014 Jan;88(1):237-48
pubmed: 24155382
J Med Entomol. 2016 May;53(3):607-612
pubmed: 27032416